speb/financial-data huggingface dataset:
CNR.TO balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 327000000.00
CNR.TO income_statement (annual, 2024-12-31) — Total Unusual Items: -46000000.00
CNR.TO income_statement (quarterly, 2024-12-31) — Total Unusual Items: 32000000.00
CNR.TO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -46000000.00
CNR.TO income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 32000000.00
CNR.TO balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 900000.00
CNR.TO balance_sheet (annual, 2024-12-31) — Treasury Stock: 129000000.00
CNR.TO balance_sheet (annual, 2024-12-31) — Working Capital: -1357000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 167000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 4403000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 2515000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1257000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 366000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 627800000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Basic EPS: 1.85
CNR.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 401000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -519000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 341000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 3515000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 232000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 232000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -557000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -783000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -538000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 1164000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -137000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Change In Inventory: -88000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -142000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Change In Payable: -137000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -137000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Change In Receivables: -88000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -455000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -88000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -157000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 3515000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -557000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 21624000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -162000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2626000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 2676000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Current Debt: 1795000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1795000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 4310000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 21000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Deferred Tax: 21000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Defined Pension Benefit: 4656000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 493000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 493000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 628300000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: 1.85
CNR.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 1161000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — EBIT: 1760000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — EBITDA: 2253000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 0.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 480000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 232000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -783000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 645000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 0.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -1007000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 491000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 48903000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Gross Profit: 1777000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 212000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Interest Expense: 233000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 233000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 292000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Inventory: 809000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 42416000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -538000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 5513000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 341000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 18997000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 19338000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -24000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -162000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Net Debt: 20560000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Net Income: 1161000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 1161000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 1161000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1161000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1161000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 1161000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 1161000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: -233000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -129000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -24000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -233000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 28000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -19000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 48903000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -519000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: -105000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 21133000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 677000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 10981000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 677000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 10981000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 480000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 2253000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Normalized Income: 1161000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 1164000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -103000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Operating Income: 1610000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 4288000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 627500000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: -12000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 366000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -1007000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: 150000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 47000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 670000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 150000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 167000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Other Properties: 472000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Payables: 2515000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 2515000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Pension And Employee Benefit Expense: -103000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Pretax Income: 1527000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 37000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Properties: 48431000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -519000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 1257000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 2626000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 493000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Rent Expense Supplemental: 118000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -5642000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -162000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 12000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 18880000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 0.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 628400000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Short Term Debt Issuance: 5513000000.00
CNR.TO cash_flow (quarterly, 2025-03-31) — Short Term Debt Payments: -5618000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 21624000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 21133000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CNR.TO income_statement (quarterly, 2025-03-31) — Tax Provision: 366000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.24
CNR.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 57403000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 40621000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 21133000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 21624000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 2793000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 35779000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 54727000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 31469000000.00
CNR.TO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 1610000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 900000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 130000000.00
CNR.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: -1634000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 189000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 4272000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 2385000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 1131000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 389000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 627400000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Basic EPS: 1.87
CNR.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 244000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -805000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 329000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 3510000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 216000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 216000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -556000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -522000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -823000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 1745000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -25000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Change In Inventory: -22000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 17000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Change In Payable: -25000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -25000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Change In Receivables: 131000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 101000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 131000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: 400000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 3510000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -556000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 21536000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -303000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2445000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 2867000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Current Debt: 1124000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 1124000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 3509000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 77000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Deferred Tax: 77000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Defined Pension Benefit: 4769000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 489000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 489000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 628000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.87
CNR.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 1172000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — EBIT: 1780000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — EBITDA: 2269000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -4000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 472000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 640000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -522000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 940000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: 0.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -1429000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 484000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 48027000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Gross Profit: 1827000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 265000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Interest Expense: 219000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 219000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 192000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Inventory: 817000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 41961000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -823000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 6739000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 329000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 19301000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 19630000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 995000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -25000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -303000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Net Debt: 20209000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Net Income: 1172000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 1172000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 1172000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 1172000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 1172000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 1172000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 1172000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: -219000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 382000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 970000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -219000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -49000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -18000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 48027000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -805000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: -588000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 21052000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 629000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 10875000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 629000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 10875000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 472000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 2269000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Normalized Income: 1172000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 1745000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -101000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Operating Income: 1638000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 4090000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 625400000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 279000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -1429000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: 142000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 7000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 754000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 142000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 189000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Other Properties: 456000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Payables: 2385000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 2385000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Pension And Employee Benefit Expense: -101000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Pretax Income: 1561000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 4000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Properties: 47571000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -805000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 1131000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2445000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 489000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Rent Expense Supplemental: 105000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -6357000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -303000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 424000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 19200000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 626300000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Short Term Debt Issuance: 5744000000.00
CNR.TO cash_flow (quarterly, 2025-06-30) — Short Term Debt Payments: -6332000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 21536000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 21052000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CNR.TO income_statement (quarterly, 2025-06-30) — Tax Provision: 389000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.25
CNR.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 56776000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 40837000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 20754000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 21536000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 2634000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 35240000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 53909000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 31731000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 1638000000.00
CNR.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
CNR.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 900000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 134000000.00
CNR.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: -642000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 161000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 4165000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 2607000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 1246000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 404000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 640000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -1105000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 339000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 3468000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 214000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 214000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -550000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -1209000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -1120000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 1913000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 233000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Change In Inventory: 43000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 12000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Change In Payable: 233000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 233000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Change In Receivables: -83000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 205000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -83000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -416000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 3468000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -550000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 21273000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -1039000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 2398000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 2512000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Current Debt: 1566000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1566000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 4173000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 92000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Deferred Tax: 92000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Defined Pension Benefit: 4882000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 500000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 500000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 1139000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — EBIT: 1734000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — EBITDA: 2234000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 2000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 470000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 226000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -1209000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 808000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Ppe: 0.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -1251000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 500000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 49129000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Gross Profit: 1767000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 231000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Interest Expense: 227000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 227000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 279000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Inventory: 780000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 42393000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -1120000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 6979000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 339000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 19554000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 19893000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -371000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -1039000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Net Debt: 20906000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Net Income: 1139000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 1139000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 1139000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 1139000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 1139000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 1139000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 1139000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: -227000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 348000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -371000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -227000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 31000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -15000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 49129000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -1105000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: 719000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 20773000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 631000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 11040000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 631000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 11040000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 470000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 2234000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Normalized Income: 1139000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 1913000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -101000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Operating Income: 1606000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 3991000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 617700000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 260000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -1251000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: 128000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 78000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 805000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 128000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 161000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Other Properties: 461000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Payables: 2607000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 2607000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Pension And Employee Benefit Expense: -101000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Pretax Income: 1507000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 1000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Properties: 48668000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -1105000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 1246000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 2398000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 500000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Rent Expense Supplemental: 103000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -6631000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -1039000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 12000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 18789000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 618700000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Short Term Debt Issuance: 6979000000.00
CNR.TO cash_flow (quarterly, 2025-09-30) — Short Term Debt Payments: -6260000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 21273000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 20773000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CNR.TO income_statement (quarterly, 2025-09-30) — Tax Provision: 368000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.24
CNR.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 57654000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 40827000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Total Debt: 21459000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 21273000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 2559000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 36381000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 55142000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 32208000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 1606000000.00
CNR.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
CNR.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 1000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 137000000.00
CNR.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: -1661000000.00
CNR.TO income_statement (annual, 2025-12-31) — +Operating Expense: 745000000.00
CNR.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 228000000.00
CNR.TO income_statement (annual, 2025-12-31) — +Total Revenue: 17304000000.00
CNR.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 4464000000.00
CNR.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 890000000.00
CNR.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 890000000.00
CNR.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 1117000000.00
CNR.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 1117000000.00
CNR.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -18519000000.00
CNR.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -18519000000.00
CNR.TO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 415000000.00
CNR.TO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 415000000.00
CNR.TO balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -19000000.00
CNR.TO balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -19000000.00
CNR.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 623100000.00
CNR.TO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 615400000.00
CNR.TO income_statement (annual, 2025-12-31) — Basic EPS: 7.58
CNR.TO income_statement (quarterly, 2025-12-31) — Basic EPS: 2.03
CNR.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 401000000.00
CNR.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 226000000.00
CNR.TO balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 2579000000.00
CNR.TO balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 2579000000.00
CNR.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -3658000000.00
CNR.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -1229000000.00
CNR.TO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 424000000.00
CNR.TO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 424000000.00
CNR.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 3454000000.00
CNR.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 3454000000.00
CNR.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 350000000.00
CNR.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 350000000.00
CNR.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 350000000.00
CNR.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 350000000.00
CNR.TO cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -2208000000.00
CNR.TO cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -545000000.00
CNR.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -3371000000.00
CNR.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -857000000.00
CNR.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -3713000000.00
CNR.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1232000000.00
CNR.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 7049000000.00
CNR.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 2227000000.00
CNR.TO cash_flow (annual, 2025-12-31) — Change In Account Payable: 220000000.00
CNR.TO cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 149000000.00
CNR.TO cash_flow (annual, 2025-12-31) — Change In Inventory: -24000000.00
CNR.TO cash_flow (quarterly, 2025-12-31) — Change In Inventory: 43000000.00
CNR.TO cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -123000000.00
CNR.TO cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -10000000.00
CNR.TO cash_flow (annual, 2025-12-31) — Change In Payable: 220000000.00
CNR.TO cash_flow (quarterly, 2025-12-31) — Change In Payable: 149000000.00
CNR.TO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 220000000.00
CNR.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 149000000.00
CNR.TO cash_flow (annual, 2025-12-31) — Change In Receivables: 92000000.00
CNR.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: 132000000.00
CNR.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: 165000000.00
CNR.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 314000000.00
CNR.TO cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 92000000.00
CNR.TO cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 132000000.00
CNR.TO cash_flow (annual, 2025-12-31) — Changes In Cash: -35000000.00
CNR.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: 138000000.00
CNR.TO balance_sheet (annual, 2025-12-31) — Common Stock: 3454000000.00
CNR.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 3454000000.00
CNR.TO cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -2208000000.00
CNR.TO cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -545000000.00
CNR.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 21568000000.00
CNR.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 21568000000.00
CNR.TO cash_flow (annual, 2025-12-31) — Common Stock Payments: -2115000000.00
CNR.TO cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -611000000.00
CNR.TO income_statement (annual, 2025-12-31) — Cost Of Revenue: 9972000000.00
CNR.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 2503000000.00
CNR.TO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 957000000.00
CNR.TO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 957000000.00
CNR.TO balance_sheet (annual, 2025-12-31) — Current Assets: 2471000000.00
CNR.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 2471000000.00
CNR.TO balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 108000000.00
CNR.TO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 108000000.00
CNR.TO balance_sheet (annual, 2025-12-31) — Current Debt: 906000000.00
CNR.TO balance_sheet (quarterly, 2025-12-31) — Current Debt: 906000000.00
CNR.TO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1014000000.00
CNR.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1014000000.00
CNR.TO balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 7000000.00
CNR.TO balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 7000000.00
CNR.TO balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 7000000.00
CNR.TO balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 7000000.00
CNR.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 3696000000.00
CNR.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 3696000000.00
CNR.TO balance_sheet (annual, 2025-12-31) — Current Provisions: 109000000.00
CNR.TO balance_sheet (quarterly, 2025-12-31) — Current Provisions: 109000000.00
CNR.TO cash_flow (annual, 2025-12-31) — Deferred Income Tax: 334000000.00
CNR.TO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 144000000.00
CNR.TO cash_flow (annual, 2025-12-31) — Deferred Tax: 334000000.00
CNR.TO cash_flow (quarterly, 2025-12-31) — Deferred Tax: 144000000.00
CNR.TO balance_sheet (annual, 2025-12-31) — Defined Pension Benefit: 5362000000.00
CNR.TO balance_sheet (quarterly, 2025-12-31) — Defined Pension Benefit: 5362000000.00
CNR.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 1938000000.00
CNR.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 456000000.00
CNR.TO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1938000000.00
CNR.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 456000000.00
CNR.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 623700000.00
CNR.TO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 616000000.00
CNR.TO income_statement (annual, 2025-12-31) — Diluted EPS: 7.57
CNR.TO income_statement (quarterly, 2025-12-31) — Diluted EPS: 2.03
CNR.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 4720000000.00
CNR.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 1248000000.00
CNR.TO income_statement (annual, 2025-12-31) — EBIT: 7177000000.00
CNR.TO income_statement (quarterly, 2025-12-31) — EBIT: 1903000000.00
CNR.TO income_statement (annual, 2025-12-31) — EBITDA: 9115000000.00
CNR.TO income_statement (quarterly, 2025-12-31) — EBITDA: 2359000000.00
CNR.TO cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -3000000.00
CNR.TO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -1000000.00
CNR.TO balance_sheet (annual, 2025-12-31) — Employee Benefits: 457000000.00
CNR.TO balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 457000000.00
CNR.TO cash_flow (annual, 2025-12-31) — End Cash Position: 363000000.00
CNR.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 363000000.00
CNR.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: -3371000000.00
CNR.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -857000000.00
CNR.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: 3391000000.00
CNR.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 998000000.00
CNR.TO cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 0.00
CNR.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 48000000.00
CNR.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: 48000000.00
CNR.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 32000000.00
CNR.TO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -1067000000.00
CNR.TO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -1067000000.00
CNR.TO balance_sheet (annual, 2025-12-31) — Goodwill: 100000000.00
CNR.TO balance_sheet (quarterly, 2025-12-31) — Goodwill: 100000000.00
CNR.TO balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 220000000.00
CNR.TO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 220000000.00
CNR.TO balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 1136000000.00
CNR.TO balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 1136000000.00
CNR.TO balance_sheet (annual, 2025-12-31) — Gross PPE: 68107000000.00
CNR.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 68107000000.00
CNR.TO income_statement (annual, 2025-12-31) — Gross Profit: 7332000000.00
CNR.TO income_statement (quarterly, 2025-12-31) — Gross Profit: 1961000000.00
CNR.TO balance_sheet (annual, 2025-12-31) — Hedging Assets Current: 0.00
CNR.TO balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 0.00
CNR.TO cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 935000000.00
CNR.TO cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 227000000.00
CNR.TO income_statement (annual, 2025-12-31) — Interest Expense: 913000000.00
CNR.TO income_statement (quarterly, 2025-12-31) — Interest Expense: 234000000.00
CNR.TO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 913000000.00
CNR.TO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 234000000.00